1. Home
  2. VRNA vs NICE Comparison

VRNA vs NICE Comparison

Compare VRNA & NICE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNA
  • NICE
  • Stock Information
  • Founded
  • VRNA 2005
  • NICE 1986
  • Country
  • VRNA United Kingdom
  • NICE Israel
  • Employees
  • VRNA N/A
  • NICE N/A
  • Industry
  • VRNA Biotechnology: Pharmaceutical Preparations
  • NICE Computer Software: Prepackaged Software
  • Sector
  • VRNA Health Care
  • NICE Technology
  • Exchange
  • VRNA Nasdaq
  • NICE Nasdaq
  • Market Cap
  • VRNA 8.3B
  • NICE 8.7B
  • IPO Year
  • VRNA 2017
  • NICE 1996
  • Fundamental
  • Price
  • VRNA $105.79
  • NICE $142.85
  • Analyst Decision
  • VRNA Buy
  • NICE Buy
  • Analyst Count
  • VRNA 11
  • NICE 13
  • Target Price
  • VRNA $114.10
  • NICE $204.46
  • AVG Volume (30 Days)
  • VRNA 1.4M
  • NICE 797.4K
  • Earning Date
  • VRNA 08-06-2025
  • NICE 08-14-2025
  • Dividend Yield
  • VRNA N/A
  • NICE N/A
  • EPS Growth
  • VRNA N/A
  • NICE 39.25
  • EPS
  • VRNA N/A
  • NICE 8.36
  • Revenue
  • VRNA $221,673,000.00
  • NICE $2,838,467,000.00
  • Revenue This Year
  • VRNA $896.59
  • NICE $9.17
  • Revenue Next Year
  • VRNA $77.56
  • NICE $7.00
  • P/E Ratio
  • VRNA N/A
  • NICE $17.07
  • Revenue Growth
  • VRNA N/A
  • NICE 11.39
  • 52 Week Low
  • VRNA $24.50
  • NICE $127.00
  • 52 Week High
  • VRNA $105.89
  • NICE $200.65
  • Technical
  • Relative Strength Index (RSI)
  • VRNA 68.01
  • NICE 45.67
  • Support Level
  • VRNA $105.23
  • NICE $138.10
  • Resistance Level
  • VRNA $105.81
  • NICE $142.74
  • Average True Range (ATR)
  • VRNA 0.25
  • NICE 4.30
  • MACD
  • VRNA -0.36
  • NICE 0.76
  • Stochastic Oscillator
  • VRNA 87.88
  • NICE 69.11

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

About NICE NICE Ltd

NICE Ltd is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.

Share on Social Networks: